Insider trades
Marcia Belvin, Chief Officer of CytomX Therapeutics CTMX, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $202.2K. The latest trade was on 03/17.
Marcia Belvin
SVP, Chief Scientific Officer
- Company
- CytomX Therapeutics CTMX
- First filing
- 23/03/29
- Trades
- 30 trades
- Buys / sales
- 0 / 7
- 12-month net buying
- −$202.2K
- Last trade
- 03/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 03/17 | 03/19 | 31,492 sh | $6.42 | $202,178.64 | −9.5% | |
| Open-market sale | 25/06/16 | 25/06/17 | 13,884 sh | $2.69 | $37,347.96 | −4.9% | |
| Open-market sale | 25/03/18 | 25/03/20 | 19,512 sh | $0.60 | $11,707.2 | −7.3% | |
| Open-market sale | 24/08/20 | 24/08/22 | 4,181 sh | $1.23 | $5,142.63 | −2.3% | |
| Open-market sale | 24/03/19 | 24/03/21 | 12,795 sh | $2.09 | $26,741.55 | −7.1% | |
| Open-market sale | 23/12/20 | 23/12/22 | 4,077 sh | $1.38 | $5,626.26 | −2.6% | |
| Open-market sale | 23/09/22 | 23/09/22 | 4,119 sh | $1.30 | $5,354.7 | −2.7% |